Echosens Appoints Romain Baujard as New Group CEO to Propel Liver Health Innovation
Echosens Welcomes Romain Baujard as New CEO
In a significant transition for the healthcare diagnostics sector, Echosens has announced the appointment of Romain Baujard as their new Group Chief Executive Officer, effective May 1, 2026. This leadership change follows the retirement of Dominique Legros, who has been at the helm of the company since 2019. Under Legros' stewardship, Echosens has experienced remarkable global expansion and increased acceptance of its innovative medical technologies.
Echosens, a prominent player in the field of non-invasive medical diagnostics, aims to enhance liver health as a crucial component in managing cardiometabolic diseases. This strategic direction is reinforced by the support of Inner Mongolia FuRui Medical Science, a leading high-tech healthcare provider, and Astorg, a prominent pan-European private equity firm. Together, they are helping Echosens embark on its next growth phase, emphasizing the importance of liver health in cardiometabolic treatment protocols.
Since joining Echosens in 2015, Romain Baujard has held various influential positions, most recently serving as the Vice President of Pharmaceuticals. His multifaceted experience has encompassed global marketing, international business operations, and strategic partnerships with top pharmaceutical companies. These alliances have been crucial in positioning Echosens at the intersection of liver health management and emerging cardiometabolic therapies, an area that is gaining significant attention within the clinical community and attracting increased investment.
“I am honored to take on this responsibility at a pivotal moment for Echosens,” said Baujard. “Innovation in cardiometabolic disease management is accelerating, and liver assessment is becoming paramount to how patients are evaluated and managed. Our aim is to integrate liver assessment as a key element of routine, large-scale healthcare.” He further stated that the company is committed to enhancing access to their technologies, supporting physicians across diverse specialties, and leveraging digital and AI capabilities to foster early diagnosis and more effective risk management.
Dominique Legros, reflecting on his tenure, expressed pride in Echosens’ achievements and the impact of their contributions to global healthcare pathways. “Leading Echosens has been a privilege. Our goal has always been to empower healthcare providers to make informed decisions based on clinical data, ultimately improving patient outcomes. The importance of liver health cannot be overstated, and I am proud of what our teams have accomplished to promote this message globally.” Legros is confident that Baujard is the right leader to guide Echosens into the next era of growth.
Echosens' stakeholders, including Co-founder Laurent Sandrin, reiterated their gratitude for Legros’ leadership, acknowledging the solid foundation he has built through increased clinical adoption and global outreach. They expressed enthusiasm for Baujard’s ascension, noting his extensive experience and remarkable achievements within the organization.
About Echosens
Echosens stands as a global leader in non-invasive liver health assessment solutions. Through its innovative FibroScan® technology and an ever-expanding digital ecosystem, the company is dedicated to making liver health a cornerstone of cardiometabolic care, emphasizing its significance in improving patient outcomes.
About Inner Mongolia FuRui Medical Science Co., Ltd.
Founded in 1998 and based in Beijing, Inner Mongolia FuRui Medical Science is a high-tech healthcare company that focuses on preventing, diagnosing, treating, and managing liver diseases. Their mission is to protect families from liver cancer, and they are publicly listed on the Shenzhen Stock Exchange (300049).
About Astorg
Astorg is a leading pan-European private equity firm, managing over €23 billion in assets. The firm partners with entrepreneurs and management teams to acquire international market leaders based in Europe or the United States, providing strategic guidance, governance, and necessary capital to achieve growth objectives. Renowned for their entrepreneurial culture and long-term responsiveness to shareholders, Astorg boasts deep expertise across healthcare, technology, and business service sectors, operating from offices in Luxembourg, London, Paris, New York, Frankfurt, and Milan.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.